Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias

NCT ID
NCT07839286
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Callahan-Young LLC DBA Jigsawdio
Conditions
Alzheimer Disease, Dementia, Mild Cognitive Impairment

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Evaluating the Health Benefits of Jigsawdio: A Novel Multisensory Jigsaw Puzzle-Based Platform for Alzheimer's Disease and Related Dementias

Enrollment: 80 participants (Estimated).

What is being studied

  • Behavioral: Jigsawdio Multisensory Puzzle Platform
  • Behavioral: Standard Jigsaw Puzzle Activity

Who may be eligible

Ages
60 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: 1. Age: 60 years or older. 2. Able to communicate fluently in English. 3. Mild cognitive impairment or mild dementia based on an existing diagnosis or study screening procedures. 4. Has an informant and a puzzle creator who know the participant and are willing to participate in the study; the same person may serve in both roles. Exclusion Criteria: 1. Severe uncorrected visual or hearing impairment that would prevent puzzle use. 2. Severe motor impairment that would prevent puzzle use. 3. Concurrent participation in a similar program or Alzheimer's disease intervention study. 4. Current hospice care or terminal illness. 5. Plans to relocate within three months after the baseline assessment. 6. History of a serious mental illness, such as bipolar disorder or schizophrenia, that would interfere with study participation. 7. Unable to provide informed consent and no legally authorized representative is available

Study locations

2 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • North Carolina, United States: 1
  • Texas, United States: 1

Sample of listed locations

  • Duke University — Durham, North Carolina, 27710, United States — Site recruitment status not specified in the registry data
  • Texas A&M University — College Station, Texas, 77843, United States — Site recruitment status not specified in the registry data

Study details

Start date
October 1, 2026
Primary completion date
May 1, 2027
Completion date
May 1, 2027
First posted
September 24, 2026
Collaborators
Duke University, National Institute on Aging (NIA), Texas A&M University

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07839286
Registry last updated
September 25, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07839286 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Alzheimers Disease studies | Clinical trial FAQ